3-hydroxy-L-valine L-peptide linking ATOMP C5 H11 N O3 VAL L-beta-hydroxyvaline 0 2008-06-02 2020-06-17 N REL 133.146 V HVA N Corina N 2RPL PDBJ N N 0 1 N N N 8.076 -0.651 -3.447 -0.030 1.894 0.518 N HVA 1 CA C 0 1 N N S 7.364 -1.807 -4.001 0.081 0.438 0.679 CA HVA 2 CB C 0 1 N N N 7.595 -1.895 -5.531 -1.079 -0.245 -0.049 CB HVA 3 CG1 C 0 1 N N N 9.045 -2.097 -5.973 -1.034 -1.751 0.221 CG1 HVA 4 CG2 C 0 1 N N N 6.768 -3.024 -6.163 -2.405 0.325 0.458 CG2 HVA 5 OG3 O 0 1 N N N 7.202 -0.679 -6.123 -0.965 -0.010 -1.454 OG3 HVA 6 C C 0 1 N N N 7.668 -3.114 -3.248 1.388 -0.034 0.095 C HVA 7 O O 0 1 N N N 8.818 -3.561 -3.228 1.975 0.655 -0.705 O HVA 8 OXT O 0 1 N Y N 6.645 -3.770 -2.691 1.899 -1.219 0.463 OXT HVA 9 H H 0 1 N N N 8.238 -0.795 -2.471 0.687 2.371 1.043 H HVA 10 H2 H 0 1 N Y N 8.952 -0.542 -3.918 0.001 2.154 -0.456 H2 HVA 11 HA H 0 1 N N N 6.286 -1.654 -3.845 0.044 0.185 1.738 HA HVA 12 HG11 H 0 0 N N N 9.091 -2.146 -7.071 -1.121 -1.930 1.293 HG11 HVA 13 HG12 H 0 0 N N N 9.657 -1.255 -5.617 -1.860 -2.237 -0.297 HG12 HVA 14 HG13 H 0 0 N N N 9.430 -3.036 -5.548 -0.089 -2.157 -0.140 HG13 HVA 15 HG21 H 0 0 N N N 6.570 -2.787 -7.219 -2.437 1.397 0.265 HG21 HVA 16 HG22 H 0 0 N N N 7.327 -3.969 -6.098 -3.231 -0.162 -0.061 HG22 HVA 17 HG23 H 0 0 N N N 5.814 -3.124 -5.625 -2.492 0.145 1.529 HG23 HVA 18 HOG3 H 0 0 N N N 7.114 -0.013 -5.451 -1.668 -0.415 -1.979 HOG3 HVA 19 HXT H 0 1 N Y N 6.959 -4.581 -2.309 2.739 -1.478 0.061 HXT HVA 20 sing N N 1 sing N N 2 sing N N 3 sing N N 4 sing N N 5 sing N N 6 doub N N 7 sing N N 8 sing N N 9 sing N N 10 sing N N 11 sing N N 12 sing N N 13 sing N N 14 sing N N 15 sing N N 16 sing N N 17 sing N N 18 sing N N 19 O=C(O)C(N)C(O)(C)C CC(C)(O)[C@H](N)C(O)=O CC(C)(O)[CH](N)C(O)=O CC(C)([C@@H](C(=O)O)N)O CC(C)(C(C(=O)O)N)O InChI=1S/C5H11NO3/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m1/s1 LDRFQSZFVGJGGP-GSVOUGTGSA-N 3-hydroxy-L-valine (2S)-2-amino-3-hydroxy-3-methyl-butanoic acid PDBJ RCSB PDBE